ADCT

ADCT

USD

ADC Therapeutics SA Common Shares

$4.040-0.050 (-1.222%)

Prix en Temps Réel

Healthcare
Biotechnologie
Suisse

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$4.090

Haut

$4.140

Bas

$3.630

Volume

1.21M

Fondamentaux de l'Entreprise

Capitalisation Boursière

454.5M

Industrie

Biotechnologie

Pays

Switzerland

Statistiques de Trading

Volume Moyen

0.89M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $1.05Actuel $4.040Haut $4.8

Actualités Connexes

PR Newswire

ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today reported...

Voir plus
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
PR Newswire

ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that...

Voir plus
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025
PR Newswire

ADC Therapeutics to Present at November Investor Conferences

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced...

Voir plus
ADC Therapeutics to Present at November Investor Conferences

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.